An international drug purchase facility, designed to contribute to scaling up access to treatment for HIV/AIDS, malaria and tuberculosis, primarily for people in low-income countries, by leveraging price reductions for quality diagnostics and medicines and accelerating the pace at which these are made available. UNITAID provides a sustained and strategic market intervention that aims both to decrease the price of medicines for priority diseases and to increase the supply of drugs and diagnostics. UNITAID collects most of its funds from a levy or 'tax' on airline tickets. Originally founded by Brazil, Chile, France, Norway and the United Kingdom.
No numerical targets were set.
No numerical targets were set, thus it is difficult to measure a gap.